文献速递肺血管病与心包/心肌炎

肺动脉去神经术治疗肺动脉内膜剥脱术后残余肺动脉高压

Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

12个月时PADN组肺血管阻力平均降低258±135 dyn·s·cm⁻⁵,优于药物组的149±73 dyn·s·cm⁻⁵(组间差109,95%CI 45–171,p=0.001);6分钟步行距离亦显著改善(470±84 m vs 399±116 m,p=0.03)。

要点

  • PEA术后残余CTEPH患者行PADN可显著降低12个月PVR。
  • PADN组6分钟步行距离较药物治疗组显著提高。
  • 两组各有1例腹股沟血肿,均无后遗症。

核心结论

  • PEA术后残余CTEPH患者行PADN在12个月随访时显著降低PVR并改善6分钟步行距离。

研究设计与样本

  • PADN组(n=25)采用远程磁导航消融,MED组(n=25)接受利奥西呱并行假手术(仅标测不消融)。
  • 入组标准为右心导管平均肺动脉压≥25 mm Hg或PVR>400 dyn·s·cm⁻⁵。
  • 主要终点为随机化后12个月PVR。

主要发现

  • 12个月PVR平均降低:PADN组258±135 dyn·s·cm⁻⁵,MED组149±73 dyn·s·cm⁻⁵。
  • 组间平均差109 dyn·s·cm⁻⁵(95%CI 45–171,p=0.001)。
  • 6分钟步行距离:PADN组470±84 m,MED组399±116 m(p=0.03)。
  • 术后每组各1例腹股沟血肿,均无后遗症解决。

临床怎么用

  • 对于PEA术后至少6个月、药物达标的残余CTEPH患者,可考虑PADN以进一步降低PVR并改善运动耐量。

局限性

  • 随访时间为12个月,长期疗效与安全性未明确。
  • MED组使用利奥西呱且行假手术,PADN的独立效应需考虑背景治疗影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary artery denervation (PADN) procedure has not been applied to patients with residual chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary endarterectomy (PEA). OBJECTIVES: This study sought to assess the safety and efficacy of PADN using remote magnetic navigation in patients with residual CTEPH after PEA. METHODS: Fifty patients with residual CTEPH despite medical therapy at least 6 months after PEA, who had mean pulmonary artery pressure ≥25 mm Hg or pulmonary vascular resistance (PVR) > 400 dyn‧s‧cm-5 based on right heart catheterization were randomized to treatment with PADN (PADN group; n = 25) using remote magnetic navigation for ablation or medical therapy with riociguat (MED group; n = 25). In the MED group, a sham procedure with mapping but no ablation was performed. The primary endpoint was PVR at 12 months after randomization. Key secondary endpoint included 6-min walk test. RESULTS: After PADN procedure, 2 patients (1 in each group) developed groin hematoma that resolved without any consequences. At 12 months, mean PVR reduction was 258 ± 135 dyn‧s‧cm-5 in the PADN group versus 149 ± 73 dyn‧s‧cm-5 in the MED group, mean between-group difference was 109 dyn‧s‧cm-5 (95% confidence interval: 45 to 171; p = 0.001). The 6-min walk test distance was significantly increased in the PADN group as compared to distance in the MED group (470 ± 84 m vs. 399 ± 116 m, respectively; p = 0.03). CONCLUSIONS: PADN in patients with residual CTEPH resulted in substantial reduction of PVR at 12 months of follow-up, accompanied by improved 6-min walk test.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Romanov A, Cherniavskiy A, Novikova N, et al. Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy. J Am Coll Cardiol. 2020. PMID: 32819465. doi:10.1016/j.jacc.2020.06.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。